Page 36 - November 2019 BarJournal
P. 36

FEATUREBUSINESS LITAGATION




        BUFFING A DENT IN THE ARMOR



        MITIGATING THE RISK OF A COLLATERAL ATTACK

        TO A STIPULATED PROTECTIVE ORDER USING THE


        OPIOID MDL AS A CASE STUDY





                         BY JAMES L. MCCRYSTAL, JR. & DEREK HARTMAN




          In 1932, Justice Brandeis famously said:   man, woman, and child each year. From   grown exponentially to incorporate some
        “Publicity is justly commended as a remedy   2010 to 2018, Ohio’s rate of accidental opi-  2,000 public entities including cities, coun-
        for social and industrial diseases. Sunlight is   oid overdoses per 100,000 rose from 9 to   ties, and Native American tribes.
        said to be the best of disinfectants; electric   27. Meanwhile, the rate of accidental opioid   In the MDL, Plaintiffs argued disclosure
        light the most efficient policeman.” Innova-  overdoses in Cuyahoga County alone tripled   of the ARCOS database would: 1) allow
        tions in technology and social media have   from 10 to 31.             the parties to identify and add previously
        forged an ever-increasing infatuation with   In recognition of the growing plague,   unknown entities involved in the manu-
        information that must be balanced against   various local and state governments initi-  facturing and distribution of opioids and
        the inalienable right to privacy. The ten-  ated lawsuits in jurisdictions throughout   to identify and remove improperly named
        sion between these competing interests has   the United States asserting various claims   Defendants;  2) allow  litigation to  proceed
        prompted some of the most important issues   against opioid manufacturers. These cases   based on meaningful, objective data, not
        being litigated in the world today. Here, in   continue  to  be  prosecuted  and  litigated  to   conjecture  or  speculation; and  3)  provide
        Cleveland, those very concerns are being   this day with a focus on how to allocate re-  invaluable, highly-specific information re-
        raised in the Opioid MDL presided over by   sponsibility amongst the various entities in-  garding historic patterns of opioid sales. The
        Judge Daniel Polster of the Northern Dis-  volved.                     DEA opposed production of the ARCOS
        trict of Ohio.                        One potential tool to allocate responsibil-  database arguing disclosure would: 1) re-
          This article focuses on the use and ef-  ity among the opioid manufacturers came to   veal investigatory records compiled for law
        fectiveness of protective orders in light of a   light in a case presided over by Chief Judge   enforcement purposes and would interfere
        recent  decision  by  the  Sixth  Circuit  Court   Edmond Sargus, Jr. of the Southern District   with enforcement proceedings; 2) violate the
        of Appeals vacating Judge Polster’s order   of Ohio known as City of Cincinnati v. Am-  DOJ’s policy which prohibits the release of
        denying The Washington Post and HD Me-  erisourceBergen Drug Corporation. In the   information related to ongoing matters; and
        dia Co. access to data contained in the Drug   fall of 2017, the City of Cincinnati notified   3) cause Defendants substantial competi-
        Enforcement Administration’s (DEA) Auto-  the Court that it intended on seeking pro-  tive harm by revealing details regarding the
        mation of Reports and Consolidated Orders   duction  of  the  ARCOS  database  from  the   scope and breadth of each manufacturer’s
                             1
        System (ARCOS) database.  This article be-  DEA  through  a  subpoena,  which  the  DEA   and distributor’s market share.  Judge Pol-
        gins with a brief background of the current   and Defendants opposed. Judge Sargus ad-  ster ordered the parties to meet and confer
        opioid epidemic that is ravaging Ohio and   vised counsel he wanted to “tee up” the   on the appropriate scope of disclosure and
        the rest of the nation.             ARCOS disclosure issue for the judge who   the terms of a stipulated protective order.
          With sales spiking from $48 million in   would be chosen to preside over the MDL.   Following a hearing, Judge Polster issued
        1996 to nearly $1.1 billion in 2000, OxyCon-  He authorized Plaintiffs to serve a subpoena   a protective order intended to prevent the
        tin was a manufacturer’s dream, but due to   on the DEA to produce the ARCOS data-  DEA’s production of the ARCOS database
        reports of overdoses and criminal activity, it   base; however, he stayed production until   from  being  publicly  disclosed.  In  this  pro-
        was also growing a reputation as a drug of   the issue had been fully briefed by the DEA   tective order, the Court ordered that disclo-
        addiction.  Despite its reputation, pills con-  and other interested parties.       sure of the ARCOS database remain confi-
        tinued to flood the market, as illustrated in a   In December 2017, the United States Ju-  dential and its use be limited to litigation or
        recent article published by The Plain Dealer.  dicial Panel on Multidistrict Litigation cre-  state and local law enforcement purposes.
          Using ARCOS data, The Plain Dealer re-  ated an MDL in the Northern District of   This protective order contained two key pro-
        ported that from 2006 to 2012, 3.4 billion   Ohio that was assigned to Judge Polster. The   visions that 1) authorized the parties to file
        opioid pills were distributed in Ohio alone.   City of Cincinnati and 63 other actions were   pleadings, motions, or other documents un-
        That  equates  to  roughly  50  pills  for  every   originally transferred to the MDL, which has   der seal or with the ARCOS data redacted;
      36 |  CLEVELAND METROPOLITAN BAR JOURNAL                                                    CLEMETROBAR.ORG
   31   32   33   34   35   36   37   38   39   40   41